The Factor VIII Inhibitor test is primarily used to detect the presence of Factor VIII inhibitory antibodies in the blood, which is crucial for patients with hemophilia A receiving Factor VIII replacement therapy. It helps diagnose, monitor, and manage treatment effectiveness while assessing abnormal immune responses that may reduce blood clotting efficiency.




